|
U.S. Hormone Replacement Therapy MarketsPublished by: Frost & Sullivan Published: Aug. 1, 1998 Table of Contents
AbstractThe future of both the estrogen replacement therapy (ERT) and thyroid hormone replacement therapy (THRT) markets is being cast by Food and Drug Administration (FDA) decisions. This Frost & Sullivan report is a guide for companies that want to take full advantage of lucrative opportunities in either segment. The report supplies vital market measurements such as target population size and market penetration rate. It also covers challenges and trends facing the industry, market forecasts, pricing analysis, revenue forecasts, and includes profiles of key industry participants.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||